Skip to main content Skip to navigation

Sources of Funding

Internal Sources of Funding

Warwick-Wellcome Translational Partnership

Breaking Translational Barriers Awards provide smaller awards of up to £10,000 to access bespoke external expertise and advice that could help move your research forward.

Breaking Translational Barriers Awards could, for example fund external consultants in areas such as regulatory approval, market research, route-to-market or any other area that could benefit your research. They are designed to fund the cost of external consultants needed to address a specific issue related to your research or to assess a specific benefit etc.

More information and how to apply can be found here

EPSRC Impact Acceleration Account (IAA) supports a range of activities to maximise impact from EPSRC funding. We expect IAA funding to add value to existing funding and take advantage of new opportunities, including interdisciplinary working and engagement of new collaborators. All IAA-funded projects must demonstrate a link to previous or current EPSRC funding, with the current exception of proposed activities addressing impact of the Covid-19 outbreak. 

Next deadline for applications: 12 June 2021 (subject to available funding)

Further information can be accessed here

BBSRC Impact Acceleration Account (IAA) supports a range of activities to maximise the potential for impact from BBSRC funding. Funding is available from April 2018 to March 2021. We expect IAA funding to add value to existing funding and take advantage of new opportunities. All IAA-funded projects must be related to previous or current BBSRC funding.

IAA funding is not intended to support activities that should already have been anticipated and supported through standard routes, e.g. Pathways to Impact, Doctoral Training Partnerships, Collaborative Training Partnerships, fundamental research; or duplicate other sources of funding for impact activities.

Next deadline for applications: 28 May 2021 (subject to available funding)

Further information can be accessed here

Innovation to Commercialisation of University Research (ICURe) is 3 month customer discovery programme designed using lean start-up methodology and funded by Innovate UK.

ICURe trains, funds and supports teams led by university early-career researchers (ECRs) to determine whether there is a market for products or services that utilise their research, science or technology. Up to £35,000 of funding is available to ‘get out of the lab’ and validate these commercially promising ideas in the marketplace.

Further information can be accessed here

IAS Awards provide up to £2500 to help colleagues develop new research ideas, collaborations, funding streams, outputs and impact, particularly encouraging ambitious and innovative ventures that are not yet at the stage where they can be funded externally. Applications are welcomed on a rolling deadline.

Further information can be found here

Knowledge Transfer Partnerships (KTPs) are one of Innovate UK's business support solutions that enable knowledge transfer between academia and industry. KTPs can range from 12 months to three years during which university experts will assist an industrial partner to create strategic and profitable change within their company via a high-flying graduate, known as the KTP Associate, who will focus on the specific project.

More details can be found here

External Sources of Funding

UKRI is a comprehensive source of information on funding and support across all academic disciplines.

More information on current funding opportunities and guidance on the application process can be accessed here

BBSRC offer a range of funding opportunities aimed at pursuing world-class bioscience research.

More information on current funding calls and guidance on creating a high-impact funding application can be found here

MRC Biomedical Catalyst/Innovate UK: Developmental Pathway Funding Scheme (DPFS) is a key part of DPFS Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices, and diagnostics, including “repurposing” of existing therapies.

More information and deadline for applications can be accessed here

The Royal Society - Short Industry Fellowship scheme enables scientists employed in industry or academia and/or their postdoctoral researcher to have shorter more dynamic engagements between academia and industry, working on a mutually beneficial and collaborative project. Collaborations between academia and early-stage companies are particularly encouraged.

More information can be accessed here

NIHR Invention for Innovation Product Development programme is a translational research funding scheme aimed at de-risking early-to-late stage medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use. Funding is available for projects that have demonstrated proof-of-concept and have a clear pathway towards adoption and commercialisation.

More information on the funding streams available and deadline for applications can be accessed here

Wellcome Innovator Awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health. Please be aware that this scheme will close to applicants during 2021.

Key dates for the final application deadline and further information can be found here